Clinical trial
Efficacy of Enteral Itopride Versus Intravenous Metoclopramide in Hospitalized Medicine Patients With Feeding Intolerance Causing by High Gastric Residual Volume: a Prospective Randomized Controlled Trial
NCT07031479 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Enteral Itopride Versus Intravenous Metoclopramide in Hospitalized Medicine Patients With Feeding Intolerance Causing by High Gastric Residual Volume: a Prospective Randomized Controlled Trial
- Lead sponsor
- Chulalongkorn University
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- July 1, 2025
- Completion date
- September 30, 2026
- Enrollment
- 86 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
feeding intolerance